Zobrazeno 1 - 10
of 280
pro vyhledávání: ''
Autor:
Michael Ziskind, Benoit Fatou, Emmanuel Bouchaert, Delphine Bertin, Nina Ogrinc, Yves-Marie Robin, Dominique Tierny, Cristian Focsa, Isabelle Fournier, Pierre-Damien Caux, Michel Salzet, Zoltan Takats
Publikováno v:
Clinical chemistry
Clinical chemistry, 2021, 67 (11), pp.1513-1523. ⟨10.1093/clinchem/hvab160⟩
Clinical chemistry, 2021, 67 (11), pp.1513-1523. ⟨10.1093/clinchem/hvab160⟩
Background Formalin-fixed paraffin-embedded (FFPE) tissue has been the gold standard for routine pathology for general and cancer postoperative diagnostics. Despite robust histopathology, immunohistochemistry, and molecular methods, accurate diagnosi
Autor:
Alena Bensussan, Chunxiao Guo, Livia S. Eberlin, Ruth L. Katz, John Q. Lin, Erik N.K. Cressman, Savitri Krishnamurthy
Publikováno v:
Clin Chem
BACKGROUNDDistinguishing adenocarcinoma and squamous cell carcinoma subtypes of non-small cell lung cancers is critical to patient care. Preoperative minimally-invasive biopsy techniques, such as fine needle aspiration (FNA), are increasingly used fo
Publikováno v:
Clinical Chemistry. 67:576-578
Autor:
Daniel Lasserson, Christopher A. O’Callaghan, Richard Stevens, Jan Y Verbakel, Emily McFadden, Julie McLellan, Jennifer Hirst, FD Richard Hobbs
Publikováno v:
Clinical Chemistry. 64:475-485
BACKGROUND The majority of patients with chronic kidney disease are diagnosed and monitored in primary care. Glomerular filtration rate (GFR) is a key marker of renal function, but direct measurement is invasive; in routine practice, equations are us
Autor:
Scott J. Strath, Taylor W. Rowley
Publikováno v:
Clinical Chemistry. 64:53-63
BACKGROUND The rapid expansion and popularity of consumer-wearable physical activity monitors (WPAMs) has enabled the integration of technology into physical activity (PA) intervention, deployment, and evaluation. This brief review reports on the acc
Autor:
Sushrut S. Waikar, Mariana Cárdenas-González, Xiaolan Zhang, Vanesa Bijol, Samir M. Parikh, Isaac E. Stillman, Jonathan Himmelfarb, Anand Srivastava, Vishal S. Vaidya, Mira Pavkovic, Ian H. de Boer, Maryam Afkarian, Helmut G. Rennke, Brad H. Rovin
Publikováno v:
Clinical Chemistry. 63:1515-1526
BACKGROUND The prevalence of chronic kidney disease (CKD) is increasing, leading to significant morbidity and mortality. Kidney biopsy remains the gold standard for diagnosing the underlying etiology of CKD, but the procedure carries complication ris
Autor:
Christina Backes, Thomas Laufer, Jochen Kohlhaas, Eckart Meese, Mustafa Kahraman, Nicole Ludwig, Tobias Fehlmann, Robert Bals, Hannah Schrörs, Andreas Keller, Thomas Wehler
Publikováno v:
Clinical Chemistry. 63:1476-1488
BACKGROUND Different work flows have been proposed to use miRNAs as blood-borne biomarkers. In particular, the method used for collecting blood from patients can considerably influence the diagnostic results. METHODS We explored whether dried blood s
Autor:
Karolina Szummer, Tomas Jernberg, Bertil Lindahl, Juan Jesus Carrero, Marie Evans, Kai M. Eggers
Publikováno v:
Clinical Chemistry. 63:1409-1417
BACKGROUND Cardiac troponin (cTn) is important for risk assessment in patients with suspected acute coronary syndrome (ACS). cTn concentrations may, however, be affected by renal dysfunction, and the clinical importance of this interrelation is not w
Autor:
Caroline Hego, Maud Milder, François-Clément Bidard, Jean-Yves Pierga, Aurore Rampanou, Alexandre Houy, Olivier Lantz, Francesca Riva, Marc-Henri Stern, Paul Cottu, Jordan Madic, Marie-Paule Sablin, Anne Vincent-Salomon, Charlotte Proudhon, Adrien Saliou
Publikováno v:
Clinical Chemistry. 63:691-699
BACKGROUND In nonmetastatic triple-negative breast cancer (TNBC) patients, we investigated whether circulating tumor DNA (ctDNA) detection can reflect the tumor response to neoadjuvant chemotherapy (NCT) and detect minimal residual disease after surg
Autor:
Torbjørn Omland, Harvey D. White
Publikováno v:
Clinical Chemistry. 63:165-176
BACKGROUND Multiple circulating biomarkers have been associated with the incidence of cardiovascular events and proposed as potential tools for risk stratification in stable ischemic heart disease (IHD), yet current guidelines do not make any firm re